Thank you for standing by. And welcome to the Sonoco Products Company Fourth Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. On keypad, if you would like to withdraw your question, again, press star one. Thank you.

I'd now like to turn the call over to Roger Schrum, Interim Head of Investor Relations and Communications. You may begin..

Thank you, Rob, and good morning, everyone. Yesterday evening, we issued a news release and posted an investor presentation that reviews Sonoco Products Company's fourth quarter and full year results, along with our 2025 guidance. Both are posted on the investor relations sections of our website at sonoco.com.

A replay of today's conference call will be available on our website, and we'll post a transcript later this week. If you would turn to slide two, I would remind you that during today's call, we will discuss a number of forward-looking statements based on current expectations, estimates, and projections.

These statements are not guarantees of future performance and are subject to certain risks and uncertainties. Therefore, actual results may differ materially.

Additionally, today's presentation includes the use of non-GAAP financial measures, which management believes provides useful information to investors about the company's financial condition and results of operation.

Further information about the company's use of non-GAAP financial measures, including definitions as well as reconciliations to GAAP measures, is available under the Investor Relations section of our website.

Finally, references to certain financial metrics along with corresponding year-over-year comparable results made on this call are on a full company basis except when specifically referred to for continuing operations or for discontinued operations.

Joining me this morning are Howard Coker, President and CEO, Rodger Fuller, Chief Operating Officer, and Jerry Cheatham, Interim Chief Financial Officer. For today's call, we will have prepared remarks followed by Q&A. If you will turn to slide four in our presentation, I will now turn the call over to Howard..

Thank you, Roger. Welcome back. 2024 was a milestone year for Sonoco Products Company as we created global leadership in sustainable metal packaging following the December 4th acquisition of Eviosus, Europe's leading food cans and enclosure manufacturer.

As slide five shows, we jump-started the integration process with day one celebrations with large groups of employees at several Eviosus facilities. Our teams are now deep in the process of integrating into Sonoco Metal Packaging EMEA and achieving our two-year $100 million synergy target.

Also, on December 18th, we further transformed our portfolio through the announced divestiture of our thermoform and flexible packaging business, the Tophan Holdings, for approximately $1.8 billion. We're on track to complete the sale during the second quarter, having now received approval from regulators in the US, Brazil, and the UK.

We're continuing a strategic review of our remaining cold chain temperature-controlled packaging business to further focus on our metal and paper packaging, consumer, and industrial businesses. Moving to slide six, you see the key results for the fourth quarter.

Despite persistent price cost headwinds and the impact of two hurricanes earlier in the quarter, our team stayed focused on driving solid operating results. Jerry will provide the details and drivers for the quarter, but adjusted earnings per share excluding Eviosus, which we did not project in our guidance, were within our expectation.

Eviosus recorded a loss in December, and it was primarily due to interest expense that was incurred in operations that experienced the normal year-end holiday season slowdown. Rest assured, Eviosus is a highly profitable, high-quality asset, and results so far in 2025 are certainly meeting our expectations.

Overall, in the fourth quarter, Sonoco Products Company produced a 5% improvement in adjusted EBITDA, and adjusted EBITDA margin expanded to nearly 15%. For all of 2024, we achieved approximately $183 million in productivity savings, equally split between our consumer and industrial segments.

As mentioned earlier, some of our operations were impacted by two hurricanes, which hit the Southeast United States in early fourth quarter, including our largest thermoforming facility in Florida, which had the roof destroyed by Hurricane Milton.

Our employees went above and beyond to minimize downtime caused by the storms while at the same time taking time to volunteer in their communities to help with cleanup and recovery efforts. Finally, Sonoco Products Company generated a better-than-expected $834 million in operating cash flow and $456 million in free cash flow.

This was the second-largest operating cash flow year by Sonoco Products Company, and we invested a record $378 million on capital projects focused on growth and productivity. Results from our multi-year "Invest in Ourselves" strategy are demonstrated through our improved productivity. Today's investments are more weighted towards growth.

If you look at slide seven, you'll see where we're continuing to invest across our businesses, including expanding greenfield paper can production in Thailand, Mexico, and in the US. All of these projects are sponsored by customers and will increase organic sales over the next several years.

And I should add, the Thailand facility is expected to become one of the world's largest paper can production sites when fully completed over the next few years.

Also, we're recapitalizing pulp tube production for adhesives and sealants for our customers who are experiencing strong demand as contractors and homeowners repair their homes and businesses from unprecedented storms and fire-related damage.

In metal packaging, we're adding capabilities to meet rising demand for aerosol cans in the US and wet pet food cans in both the US and Europe, along with customer-specific cap enclosures projects.

And finally, our industrial paper products businesses are continuing to capture targeted growth opportunities and productivity projects in the US and Europe while we continue to focus on rightsizing select markets.

Now that brief introduction, let me turn the call over to Jerry Cheatham, who took over the Interim CFO role in January and frankly is doing a great job.

I won't go over Jerry's impressive resume, but I've worked with Jerry for most of my career, including when I headed Sonoco Products Company's industrial segment and Jerry served as the group's financial leader. Jerry knows our operations extremely well, and he has the trust and respect of our global finance organization.

Jerry, welcome, and please take us through the numbers..

Thanks, Howard. I'm pleased to present the fourth quarter financial results starting on page nine of the presentation. Please note that the results are on an adjusted basis and all growth metrics are on a year-over-year basis unless otherwise stated.

The GAAP to non-GAAP EPS reconciliation is in the appendix of the presentation as well as in the press release. As Howard said, 2024 was a milestone year for Sonoco Products Company.

We made significant progress on our strategy of fewer, bigger businesses that will enable more focused investments to drive value creation through earnings growth and margin improvement.

We are confident and excited about the future and expect the leading global market positions of our two core businesses to drive greater efficiency and improve customer support. We grew adjusted EPS excluding Eviosus to $1.17, which was within the lower end of our guidance range.

The negative $0.17 related to Eviosus consisted primarily of interest expense on the related transaction financing for the time period we owned the business in 2024. The 14.7% EPS improvement year-over-year was driven by strong performance despite strong operational performance and fixed cost reduction initiatives.

Productivity was positive $41 million and marked the eighth consecutive quarter of year-over-year productivity improvement. This was further aided by low single-digit volume growth in the consumer and industrial segments and partially offset by the negative impact of price cost and lower volumes in all other businesses.

Fourth quarter net sales increased 2% to $1.4 billion excluding discontinued operations of $297 million. This favorable change was driven by low single-digit volume gains and the impact of December sales from the Eviosus acquisition that was completed on December 4th.

This was partially offset by reclassifying a recycling business as a procurement function, lower selling prices, and reduced volumes from actions to exit or divest non-strategic positions. Adjusted EBITDA of $247 million was up 5%, and adjusted EBITDA margins improved by 46 basis points to 14.9%. Page ten has our consumer segment results.

On a continuing operations basis, consumer sales were up 18% due to the Eviosus acquisition and favorable volume mix. This was partially offset by lower selling prices. Eviosus contributed 27 days of sales in December that reflected their normal sales pattern of lower sales during the holiday period.

Our global rigid containers and domestic metal packaging business both experienced low single-digit organic volume. Consumer adjusted EBITDA margins grew 9% year-over-year due to productivity and fixed cost reductions that were partially offset by negative price cost. Page eleven has our industrial segment results.

Industrial sales decreased 4% to $571 million. These results reflect the reclassification of recycling, which reduced sales by $24 million during the quarter. We also completed the exit of our industrial operations in China during the quarter. Adjusting for those actions, industrial sales would have been up 2.7% year-over-year.

Organic volumes increased by low single digits. Sales were also benefited by low single-digit improvements in selling prices due to index-based price resets. Adjusted EBITDA margins improved sequentially through the year and were up 250 basis points year-over-year in the fourth quarter driven by strong productivity.

Adjusted EBITDA increased by $11 million to $102 million, representing a 12% increase. Page twelve has the results of our all other businesses. All other sales were $88 million, and adjusted EBITDA was $8 million.

The sales and adjusted EBITDA results were negatively affected by the divestiture of Protective Solutions, a customer's new product launch in 2023 that did not repeat in our industrial plastic business, along with slowing sales from COVID vaccine distribution. Turning to page thirteen, we have our cash flow performance for the year.

Strong operating performance drove operating cash flow generation of $834 million for the year. This was the second-best year on the heels of an $883 million record year performance in 2023. We invested $378 million for the year on capital projects to enable future growth and drive margin improvement.

Now turning to page fourteen and looking ahead to 2025, our full-year guidance considers a full year of Eviosus and one full quarter of TFP. OCC is expected to average $100 for the year. We're expecting a stronger dollar in 2025 and an average effective tax rate of approximately 25%. The euro exchange rate is expected to average 1.055 for the year.

Turning to the sales bridge on page fifteen, we're projecting sales to grow by 21.5% from $6.6 billion to approximately $8 billion, primarily due to the acquisition of Eviosus net of the TFP divestiture and organic growth in our legacy businesses.

In consumer, we expect low single-digit organic growth, partially offset by negative index-based price resets. For the industrial segment, we also expect low single-digit organic volume growth and favorable price due to contractual resets with existing customers.

Volume in the all other group of businesses is expected to be mixed with organic growth varying from low single digits to mid-teens. Slide sixteen provides the summary of our key drivers of our adjusted EPS guidance.

We expect to deliver adjusted EPS growth in the range of 19% to 23% above the 2024 EPS of $5.06 that excludes the $0.17 from Eviosus in December.

Earnings in our legacy businesses are expected to grow by approximately 10% driven by continued strong operating performance, productivity, organic growth, partially offset by negative price cost due to higher fixed and other expenses.

The Eviosus acquisition is expected to be 25% accretive, and the TFP divestiture is expected to be dilutive in the range of 7% to 9%. These projected impacts reflect the associated earnings in 2025, net of the interest expense impact from the related financing and expected debt repayment.

Non-operational expenses are expected to lower EPS between $0.25 to $0.30 due to a higher effective tax rate resulting from discrete items of 2024 that we do not expect to repeat. FX headwinds and higher net interest expense. Page seventeen presents our cash flow guidance key assumptions.

We expect to have another strong year of operating cash flow performance in the range of $800 to $900 million and free cash flow between $450 to $550 million. We are targeting capital expenditures of approximately $300 million to drive growth and margin expansion opportunities.

The ratio of capital spending as a percent of net sales is expected to be slower compared to 2024 due to a higher emphasis on debt repayment. We expect volume growth to lead to a use of net working capital of approximately $25 million. Now with that, I'll turn it back over to Howard for closing remarks..

Right. Thanks, Jerry. I'll now move to slide eighteen. You know, Sonoco Products Company today is the global leader of value-added sustainable metal and fiber consumer and industrial packaging.

It has become a simpler, stronger, and more sustainable company with products, technology, and market presence that positions us to consistently win in the marketplace. Since I was honored by our board of directors five years ago to become CEO, we've gone through a strategic transformation to remove complexity and build fewer, bigger businesses.

That process has led us to divest below-margin display and packaging businesses and other smaller non-core assets. We moved away from resin-based businesses ranging from molded foam products for automobiles to plastic bottles and trays for food, beverage, and medical packaging.

We did so because we found we could not achieve the necessary scale to consistently win in the marketplace. And we've leaned into our growing aerosol and cans along with caps and closures in the US and EMEA. But we now have assembled quality assets and strong market positions.

For example, purchasing Ball Metalpack in January 2022, we've driven greater than 10% annual growth in adjusted EBITDA and continued to find opportunities for growth. We believe we can achieve similar results with Eviosus and are projecting approximately 10% improvement in adjusted EBITDA for 2025.

As mentioned earlier, another key tenet of our strategy is to invest in ourselves. As an example, over the past five years, we've made investments in our global paper can franchise that have resulted in sales growing by nearly 25%, particularly in emerging markets. And with all new paper cans that offer more market differentiation.

Our iconic integrated URB industrial paper products business is the global leader of product technology unmatched by our competitors. Through continued investment and pruning of certain lower profit businesses and markets, we have grown EBITDA in North America by approximately 40% since 2020.

And finally, the new Sonoco Products Company has become a cash-generating engine, producing approximately $1.7 billion in operating cash flow and $1 billion in free cash over the past two years.

After investing in ourselves, our capital allocation strategy is focused on reducing leverage between 3 times to 3.3 times net debt to adjusted EBITDA by the end of 2026, utilizing proceeds from divestitures, asset sales, and our strong free cash flow.

And finally, we expect to achieve an extraordinary 100 consecutive years of returning cash to our shareholders in the form of sector-leading dividends. Slide nineteen is a graphic representation of what the new Sonoco Products Company is expected to achieve in 2025, along with our businesses and served markets.

We project sales will grow approximately 20% between $7.75 billion and $8 billion. Adjusted EBITDA is expected to grow approximately 30% to between $1.3 to $1.4 billion. The cash flow from operations will remain strong between $800 and $900 million.

Finally, our mix of business is further shifting to more consumer markets, and our geographic reach will become more balanced around the world, with more than half of our sales still occurring in the United States.

Looking forward, we believe our transformed portfolio of world-class consumer and industrial packaging businesses are well-positioned to serve the challenging changing needs of our diverse global customers.

We're off to a solid start to 2025, and I believe our prospects for continued growth, margin improvement, and strong cash flow generation will continue to allow us to return greater value to our shareholders. With that, operator, we're ready to take any questions..

Thank you. We will now begin the question and answer session. If you would like to withdraw your questions, simply press star one again. Your first question comes from the line of George Staphos from Bank of America. Line is open..

Thanks. Good morning, everyone. Thanks for the details, Jerry, welcome. Roger, great to hear your voice again. Hope everybody's well.

I guess can you talk a little bit about the exit rates or early 1Q rates, depending on perspective, that you're seeing across your most important businesses? Relatedly, can you talk about how Eviosus is doing relative to the original, I want to say, $430 million of EBITDA guidance on an annualized basis? And lastly, can you talk about how much you're expecting from TFP in the first quarter? Thanks.

I might have a quick follow-on..

Sure, George. On the exit rates, you know, actually, the adjusted run rate for Eviosus looks like it's gonna be around somewhere in the neighborhood of around $390 million for 2024. This is entered into 2025. Our expectation is and our plan is a 10% increase in that number, and that's what we've got built into our guidance.

And so far, we're seeing that type of a run rate. Obviously, early with the month and a half behind us, but we're very bullish about the go-forward there. And then on the remainder of businesses, yeah, we've been seeing some sequential improvement, particularly on the metal can business here in North America.

Slight improvements to flat flattish coming out of December on the paper can business, and we've seen consecutive improvements particularly in North America on the industrial business for quarter over quarter over the last three quarters. So as we enter the New Year, we're uniquely positive about how we're starting things out.

There's a lot of uncertainty with what's going on from a macro perspective, but we control what we can control..

Yeah. Just as it relates to expectations for TFP in the first quarter, we expect their first quarter 2024 performance to be similar to what we saw in Q4 2024..

Okay. So that would be roughly $20 million-ish, $25 million if I remember correctly from the slides. And then just maybe last question. Industrial, I recognize you're seeing sequential improvement.

Was the business on plan with where you're expecting for the fourth quarter? It was somewhat below our forecast, which is neither here nor there, but just want to see, you know, if there were any things in 4Q that, you know, were either positive or negative relative to your guidance. Thank you, and I'll turn it over..

Yeah. George, this is Roger. Yeah. As far as industrial North America, we were very pleased with the fourth quarter.

As Howard already said, we've seen nice growth in our two core converting operations in North America, with the team doing a really nice job from a service and quality standpoint and winning some shares, especially in the paper mill core area. Paper volumes, URB volumes in North America were basically flat, maybe just slightly.

We did see weakness outside of North America, and I think that's what you're seeing in the numbers, George. Europe continues to be very soft. We've got work to do there, frankly, from a paper standpoint, from a capacity standpoint. We're working hard on that.

As we talked about last quarter, we took a small paper machine out of Greece over the past two quarters, so we're looking hard at the European paper platform, and pricing in Europe continues to be difficult from a competitive situation. And in Asia, across the board, in our industrial businesses in Asia, very soft volume.

We exited China, so you're seeing some of that in the numbers. We've taken a small paper machine out of Indonesia. So, frankly, the weakness is coming from outside North America. We're optimistic about North America. Price cost turned positive in North America in the fourth quarter, which was a very good sign.

We see that continuing into the first quarter. So it's outside of North America. We're working hard to get costs aligned. And we will see sequential improvement, but it'll take a little time as we run through 2025..

Okay. Thanks very much. I'll turn it over..

Your next question comes from the line of Anthony Pettinari from Citi. Line is open..

Good morning. This is actually Brian Bergmeier on for Anthony. Thank you for taking the question. My first question is just kind of from a high level. You know, I think guidance kind of points to low single-digit volume growth in 2025. Just curious what that maybe implies specifically for consumer.

You know, we'd maybe consider that to be a little bit above peers or a little bit above maybe some of the blue-chip customers. So just curious what's driving that..

Yeah, Brian. You know, if I just look at my charts here, really, we're seeing it in the two main businesses left in consumer, the metals business in North America. We saw an aggregate solid, but low single-digit type growth over the last year, quarter to quarter to quarter, actually strong in the low single digits for the full year.

And we're seeing a pickup in our global paper can business as well. So talked earlier about capital deployment. You know, a lot of those projects, the new plants in Thailand, Mexico, new lines in the US, some are in the early stages of startup, others will be starting up over a period of time.

But, you know, we're not, as we said, low single-digit type digits. We're not forecasting any great recovery. But that's where it's been driven from..

Got it. Got it. Thanks for that detail. And then maybe just within your metal businesses, you know, are you expecting maybe a better pack season in 2025? I think the North American pack was pretty weak last year. I'm curious if you think maybe you have a full recovery or a partial.

I know you just said you're not forecasting anything major, but just specifically kind of thinking about North American metal. Thank you, and I'll turn it over..

Yeah. I'd say we're not. Slightly better. I mean, beans were impacted. There were a few markets that were impacted, but as you noted, we're kind of holding things in that low single-digit up. So we're not forecasting any great type recovery, but certainly, we like where we are from a share position, particularly on aerosols.

We do have visibility of exactly where that growth is coming from. I think that if we have a great package, then that's just upside..

Your next question comes from the line of Matt Roberts from Raymond James. Your line is open..

Good morning, gentlemen. Thank you for taking the questions. If I could first follow-up on George's question earlier. Understand there's certainly a lot of moving parts. Typically, you do guide one quarter ahead as well.

So recognizing there are a lot of moving pieces, wondering if you could help frame EPS for 1Q a little bit better in terms of what you're expecting in terms of volume or any other bridge items there such as FX impacts or productivity and price costs? Thanks..

Yeah, Matt. You named it right from the very beginning. There are a lot of moving pieces. I think there'll be quite a few follow-up calls to help clean up some of the questions you guys may have. But we offset because of that with all the moving pieces going on right now, disco ops, etcetera, associated with the TFP, etcetera.

We've just decided that we would go with an annual forecast and we'll certainly update you on a quarter-by-quarter basis as we move through the year. But pretty much covers..

Very good. Thanks, Howard. And certainly understandable there. Maybe on ThermoSafe, I think it was recently in November. You're expected to sign something there in the early half of 2025 and close that in the middle of the year.

Have there been any changes in the thinking or timing there? I believe you noted volumes in the all other segment were negative exiting the year. We've heard some decelerate destocking has lingered in pharma and market.

So maybe what are you seeing in terms of volumes in that business? And while ThermoSafe is included in the 2025 guide, are there any assumptions from ThermoSafe in the leverage target? It seems like that changed a bit from the less than 3x that you were thinking previously, 24 months after Eviosus..

Hey, Matt. It's Roger. Quickly on ThermoSafe, as you mentioned, volumes were a little soft in the fourth quarter, and really that's an industry issue as you said. The pharma slows sales have slowed some. We're optimistic about 2025, however. If you look at a number of key areas that we're focused on, GLP-1 drugs is one of those.

Last year, the supply of those drugs was so tight there was a very tight restriction on the number of GLP-1 drugs that could be shipped to Plan X. Doctor's offices for samples, and as you've seen with one of the largest producers of that, they're now shipping direct to consumer, and that will positively impact our ThermoSafe business.

A lot going on in vaccines. As you know, COVID vaccines have slowed tremendously. We all understand that. But if you look at flu vaccines with the flu season we've had this year, we expect flu vaccine to be very strong in 2025. And there are new products coming out there like mist for flu vaccine. So we're still optimistic on ThermoSafe.

We've not changed what our expectations are there. We expect the divestiture process to be completed by the end of the year. That's not changed, and as you've already said, that's built into our deleveraging plan. So we're still optimistic there.

The slowdown is an industry issue, but we've got some very specific areas that we're optimistic about in 2025..

Andrew Howard, thank you all again..

Your next question comes from the line of Mark Weintraub from Seaport Research Partners. Line is open..

Thank you. Two clarifications maybe. One, can you help us with the cash flow bridge from your EPS to your free cash flow per share because you have EPS, you know, $6 to $6.20, and then you also have CapEx lower than DD&A. Not a whole lot of working capital investment, but your free cash flow per share is, you know, a good bit lower than the EPS.

If you could just help us out there, please..

Yeah. I think probably what you're seeing there, first of all, in our cash flow guidance, it is reflecting kind of a normal working capital profile. And you'll probably see the impact of some higher interest expense and a higher effective tax rate sort of pulling it down a little bit.

So those would be the two items that may be giving you a little bit of trouble in reconciling that..

Okay. I'll circle back perhaps with you guys on that after.

But, also, on metal overlap, is there anything of significance that we should be that might be included in the guide one way or the other?.

No, Mark. There really isn't. Pretty much flattish from a global perspective. So no nothing material there to talk about..

Okay. Great. And then lastly, on Eviosus, thanks for the specifics in terms of what you're expecting.

Does the number you were using include synergies for 2025, or is that ten percent increase on the $390 million yours that synergies?.

Yeah. I'm glad you asked, Mark. Synergy-wise, we had anticipated that we would achieve a fairly significant percentage of synergies in year one. As you recall, we announced the deal mid-summer. We did not expect that the UK authority, CMA, would take a deep semi-deep dive into this.

So we did not we were not able to close until the first week of December, which really put us on our heels in terms of negotiating annual contracts with our major suppliers. In fact, it turned more into ensuring that we had the necessary raw materials to run the global business.

So rather than the majority of the synergies coming in year one, we're estimating about a third of those synergies coming through, with the remainder really flowing into 2026. So not a lot of synergies there at least in terms of the context of what we had anticipated.

But certainly, we are extremely bullish, not only on the procurement side, but the deeper we get into the business through the integration and the more simplified portfolio being really two substrates now, cans and URB and converted products. The opportunity to drive even further productivity through SG&A is pretty exciting over the coming years..

I'll just add, Mark. Synergies don't necessarily all fall within that result as well. There's a spread between the other industrial businesses in Europe and some of the metal business in the US. Those synergies are really corporate-wide..

Okay. That's super helpful. Then maybe and I apologize. I know I'm going a little long just the shortfall last year Eviosus relative to what you might have been originally anticipating.

Anything specific you can point to?.

There are quite a few items. You know, obviously, they have some issues with not say obviously, but they did have some volume issues earlier in the year, surprise cost issues. You know, things that happen. I would say that general trends transaction-related disruptions were a part of it.

At the end of the day, as we noted that we're highly confident in the go-forward outlook of the business..

Your next question comes from the line of Mike Ruckson from Truist Securities. Your line is open..

Thanks very much for taking the questions, and congrats on all the progress. Just wanted to follow-up. I think, Roger, you mentioned European weakness in paper, and you quoted you mentioned how it needed having some work to do.

Any way you could expound on that, provide some more color around what you're thinking about doing in Europe to improve this? Or maybe just to continue to rationalize assets as you did in Greece..

Yeah. Good question. Yeah.

What I was referring to, you can well, most people remember, you know, six, seven years ago, we started this process in North America really highly investing in our lowest cost, our best mills and frankly, just taking out high-cost capacity and really just optimizing the network from, you know, from the paper mill side of the business.

And that's really the work that I was talking about in Europe.

As I said, we took the mill out of Greece, and then in my opinion, we just need a more hard focus on really making the difficult decisions around where should we be providing URB in Europe can we be more competitive and accelerating our push to invest in our best mills, and we've got some fantastic mills in Europe.

As I said, we've made moves in Greece. We've made a move in Ireland to get some unprofitable capacity out of the system. So in my opinion, we just need to accelerate that. We are accelerating that. It just takes time, and in some cases, it takes capital, which we're working through..

Got it. Thank you. Is that something that we should expect will be largely done this year as well? So that when you look at 2026, this will be in hindsight. You'll see improvements this year and you're up year over year..

That's in the guidance, and we're confident around that. You'll see more moves around capacity in Europe this year. So, yeah, I think you'll see improvements this year, and they'll flow into 2026, but we're actively working on it as we speak..

Perfect. Great. And then just one quick follow-up on the Eviosus. How was the integration proceeding thus far? And in the short time, or short period of time that you've owned it, anything better than expected, anything not as good? Obviously, you mentioned the synergies with most of that now coming in 2026 rather than 2025.

I just gave him some of the CMA issues, but anything that you've noticed from either positive or negative and how should we think about the $100 million of synergies and potential upside that..

And, Mike, it's Roger again. Not yeah. I think integration is going great. Frankly. You know, as we expected, you know, we inherited a very strong leadership team. You know, our cultures are a perfect fit. You know, we're well down the path of sharing best practices across, you know, all critical areas of the business.

From a customer and market opportunity standpoint, we have a couple we have some common customers of the large CPGs, the ones you would know. And we think there's a good opportunity to leverage those relationships. And there's some large CPGs that one region serves and the others don't. So we see a really good opportunity there.

So we're really the extreme focus is on serving our customers and finding new ways that value, you know, across that metal platform. From a supplier standpoint, you know, the purchasing of direct materials, tinplate, coatings, compounds, is a clear area we're focusing on. Howard's already mentioned.

You know, we could not even go to market together until January. But we're putting together a strategy as we speak to buy those direct materials globally. From an indirect material standpoint, logistics, those types of things, pallets, packaging supplies, you know, we're looking across our large European platform.

As you know, we've got a large industrial business there, paper can business there, and now with metal, we're looking at indirect transport costs logistics leveraging across that European platform. So we're very confident in the $100 million synergy target to get to that $100 million run rate by the end of 2026.

And, you know, there's also a significant opportunity to leverage SG&A across Europe. So again, shared services is a tremendous opportunity for us across those three businesses. And SG&A from an HR, an IT, a finance standpoint serving our industrial, our European businesses in metal, industrial, and paper can.

So as I start, I think the integration is going great. We're really pleased with where we are. We're confident in the synergies. We got a late start. But we've got firm plans in place to catch up..

And I just think the support from our new family members from Eviosus and their entire setup team's been fantastic. So feel really optimistic about the integration and the Eviosus business coming into this..

Thanks very much, Roger, and good luck in 2025..

Your next question comes from the line of George Staphos from Bank of America. Line is open..

Hi. Thanks for taking my follow-on question. So folks, if we could talk about productivity ex-synergy, and if you've mentioned it earlier in the remarks, forgive me for missing it.

But what do you expect for 2025 and how would the mix look across industrial and consumer? Secondly, if we think about the supply chain and Roger, you were talking earlier about how you're trying to work both direct and indirect now. And, you know, and the work's progressing.

Any issues to be concerned about relative to trade, to tariffs, and the like? How do you feel about your supply of metal? And then totally switching gears in metal itself.

Can you give us a bit more color on where you're seeing strength in aerosol? Is it coming more from construction markets? Is it coming elsewhere? And, you know, within food, what are you doing to sort of diversify the customer base that you've had traditionally or that that business has had traditionally? Thank you..

So, George, let me see if I got all of those. About productivity, for 2025. You know, roughly somewhere in the neighborhood between we're pulling back. I mean, year over year, you we've talked about it over and over again. Just massive improvement and it is a year-over-year calculation.

So I think we're, like, $180 some odd million on top of $130 plus million in 2023. This year, we're taking a more conservative view. Again, year over year around $60 to $65 million in the base business. Hopefully, we'll stay on the same kind of track that we've been on..

Yeah. Just keep in mind, George, that does flexibles and plastics is out of that. So they've been a strong contributor to the productivity. And productivity is built into the numbers you see. Which doesn't fall it won't fall out into that number that I was talking about.

So there's other pretty significant pieces of productivity in there that don't show up in that $64 million..

Yep. Right. And, George, I would add that from a mix standpoint, you know, the mix of those are pretty balanced between consumer and industrial..

Yep. And on the tariffs, we'll see how they ultimately end up. You know, we don't like them. Certainly, it's an impact here on our US business. And we have mechanisms to pass through without issue. But we're gonna do all we can to minimize the impact of that. We can.

And, frankly, you know, the diversity of the supply chain that we've now have gives us more opportunity than otherwise we would have. I would say that if you look at it for the remainder outside of the US, keep in mind that, in total, roughly 60% of our business is non-US. And serving local markets, supplied in local markets.

So the impact to your point really is on the metal side. The paper side of the business is less of an impact. Again, a little bit going on between Canada and Mexico. But we'll be able to navigate through that without any type of material issue.

In terms of strengths, you know, on the aerosol side, yeah, you know, we're just seeing, you know, the demand on the paint side of the business has increased considerably. I think that has a lot to do with the you can understand the hangover effect of COVID. And I imagine every one of us has got a few paint cans still sitting in our garages.

But paints are up. Season has been pretty strong, so we're seeing it in disinfectants as well. So yeah.

And then on, you know, on the base business, really focusing on the customers that we have and, you know, historically, there was a share position that the previous strategic owner had that got deteriorated, and we just are working harder in order to satisfy provide the service quality expected of those customers, and we're seeing that rewarded and increased slight increases in share..

Thanks very much. Good luck in the quarter..

Your next question comes from the line of Richard Carlson from Wells Fargo. Your line is open..

Hey. Good morning, guys. This is Richard in for Gabe Hajde this morning. I just wanted to double click on the 2026 leverage target if you guys could.

I know it's early for guidance, but other than the already disclosed asset sales and the Eviosus synergies, are there any other big pieces that we need to be keeping in mind when we work our models? And then on CapEx, there's a good chart you had on slide seven.

Should we think about that, you know, kind of a continued trend either towards a maintenance level, or are you focused more on a percentage of sales basis? Thank you..

Yeah. I'll let Jerry talk about the leverage. But, Richard, yeah, the CapEx is actually more weighted towards value-added. I think it's before I call somewhere around 60% of the capital that we're forecasting for the coming year is value-added versus maintenance.

So you've seen that flip over the last three or four years, and I've already talked through a number of major capital initiatives. We've got sponsored greenfield plants going up around the world. So pretty bullish about that. Understanding that, you know, if we invest a cost. And we'll see the benefit of these plans as they start ramping up.

2026, 2027, 2028. We'll talk about the leverage..

Yeah. As we said earlier on the call, you know, we're targeting to get to 3 to 3.3 times leverage by towards the end of 2026.

You know, obviously, we are moving forward with the strategic alternatives for ThermoSafe, which will, you know, those proceeds would help accelerate that, but we also believe that strong operating cash flow and strong free cash flow generation will give us confidence that we can get there. To that 3 to 3.3 times by the end of 2026.

And on your question on capital, you know, we are trying to tilt more of our capital towards a growth and value-generating standpoint. And we do expect to continue to invest in our businesses in that, you know, 4.5 to 5.5 times deal percent of sales..

Great. Thanks, guys. Best of luck in the quarter..

And that concludes our question and answer session. I will now turn the call back over to Roger Schrum for closing remarks..

I certainly want to thank everybody for joining us today, and we look forward to further discussions with you. We do have some upcoming meetings with investors and conferences that are posted on our website. So stay tuned for other updates and presentations that we have. Again, thank you for your participation. You can disconnect..

This concludes today's conference call. Thank you for joining. You may now disconnect..